Location History:
- Tokyo, JP (2009)
- Chuo-ku, JP (2011)
- Suita, JP (2008 - 2012)
Company Filing History:
4 out of 140 
2 out of 61 
2 out of 950 
Years Active: 2008-2012
Title: Fumio Samizo: Innovator in Cancer Research
Introduction
Fumio Samizo is a notable inventor based in Suita, Japan, recognized for his contributions to cancer research and therapeutic innovations. With a total of four patents to his name, he has made significant strides in developing novel medical compounds and treatments.
Latest Patents
Among his latest patents is a groundbreaking invention related to a dimerized peptide. This invention provides a novel tumor antigen peptide and its cancer vaccine, specifically a peptide dimer wherein two peptide monomers consisting of 7-30 amino acids, including at least one cysteine residue, are bound to each other through a disulfide bond. Another significant patent involves a benzothiazin-3-one compound and its intermediate, which serves as a medicine containing an active ingredient useful for treating various conditions, including arthrosis deformans, chronic articular rheumatism, cancers, and gingivitis.
Career Highlights
Fumio Samizo has worked with prominent organizations, including Dainippon Sumitomo Pharma Co., Ltd. and the International Institute of Cancer Immunology, Inc. His work in these institutions has allowed him to focus on innovative solutions in the field of cancer treatment and immunology.
Collaborations
Throughout his career, Fumio has collaborated with esteemed colleagues such as Haruo Sugiyama and Hideo Takasu. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Fumio Samizo's work exemplifies the impact of innovation in the medical field, particularly in cancer research. His patents reflect a commitment to improving therapeutic options for patients, showcasing the importance of continued research and development in this critical area.